Abrinica, Clyde .
HRN: 27-22-75 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2025
CEFTAZIDIME 1GM (VIAL)
09/24/2025
10/01/2025
IV
385mg
Q8h
PCAP C
Waiting Final Action
11/02/2025
MUPIROCIN 2%, 15G (TUBE)
11/02/2025
11/08/2025
TOPICAL
2%
BID
Infected Post-op Site
Checking Final Appropriateness
11/03/2025
CIPROFLOXACIN 500MG (TAB)
11/03/2025
11/10/2025
NGT
80mg/pptab
Q12
Pseudomonas Aeroginosa Infection
Checking Final Appropriateness